Reckitt Benckiser (LON:RB) shares sunk in early trading on Thursday after it said the “Petya” ransomware cyber attack could have an £100 million impact on revenues.
The pharmaceutical manufacturer, who make Nurofen painkillers and Durex condoms, were hit by the cyber attack that disrupted several large companies on the 27th June. Reckitt Benckiser confirmed that it would impact on its ability to fulfil orders for clients this quarter, disrupting its factories and causing delays.
In a statement on Thursday, the Slough-based company said:
“We were unable to ship and invoice some orders to customers prior to the close of the quarter. Some of our factories are currently still not operating normally but plans are in place to return to full operation.
“We expect that some of the revenue lost from the second quarter will be recovered in the third quarter. However, the continued production difficulties in some factories mean that we also expect to lose some further revenue permanently.”
Like-for-like net revenue in 2017 is now expected to slow by about 1 percent in 2017, from the 3 percent increase initially estimated to an increase of about 2 percent. The company made almost £10 billion in revenues in 2016, meaning around £100 million would be lost as a result of the attack.
Shares in Reckitt Benckiser are currently trading down 1.39 percent at 7,593.00 (1004GMT).